Schizophreniform Disorder
78
4
4
53
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
23 trials with published results (29%)
Research Maturity
53 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
12.8%
10 terminated out of 78 trials
84.1%
-2.5% vs benchmark
31%
24 trials in Phase 3/4
43%
23 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 53 completed trials
Clinical Trials (78)
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
Building a Computational Model of Auditory Hallucinations
Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode Psychosis
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
Cognitive Strategies in Early Psychosis 2
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia
MicroRNAs as Biomarkers in First Episode Schizophrenia
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
Randomized Double Blind Placebo Control Study in Patients with Schizophrenia
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
Contrasting Group Therapy Methods for Psychosis
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
rTMS in First Episode Psychosis
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia
Varenicline Adjunctive Treatment in Schizophrenia